Skip to main content

Outage notice:

Due to the global information outage that occurred this morning, Quest is taking swift action to respond, recover and restore our operations. Our Patient Services are operating with reduced capacity so you may experience longer wait and service times. Our Customer Contact teams are currently unavailable. We appreciate your patience as we work toward returning to normal operations. 


The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease

On-demand Webinar:


The objectives of this webinar include:


• A discussion of the current opportunities and challenges in diagnosing Alzheimer's disease


• A discourse on the emerging role of blood-based biomarkers (eg, P-tau, A β42/A β40, NfL) in Alzheimer's disease screening and monitoring


• An exploration of emerging treatments and new diagnostic pathways for Alzheimer's disease


Mar 29, 2022
Dr Stephen Salloway and Dr Michael Racke
Gabriele Olla

Stephen P. Salloway, MD, MS

Michael K. Racke, MD